XII. A Quantitative Comparison of the Antiaccelerator Cardiac Action of Veratramine, Veratrosine, Jervine and Pseudojervine
Abstract
1 . The antagonistic action of veratramine and jervine and of their respective glycosides, veratrosine and pseudojervine, has been studied quantitatively in the heart-lung preparation of the dog using continuous infusion of l-epinephrine under standard conditions to increase heart rate.
2. When l-epinephrine base is infused at the rate of 3 microgm. per minute the dose causing 50 per cent inhibition of acceleration (I50) is 0.16 mgm. veratramine and 7.6 mgm. jervine. Jervine has only 2 per cent of the antiaccelerator potency of veratramine. The glycosides veratrosine and pseudojervine have the same order of potency as their respective aglycones. The I50 of veratrosine is approximately 0.1 mgm.
3. The term "antiaccelerator" is introduced to denote a specific and selective antagonistic action to the positive chronotropic effect of epinephrine and of substances acting like it upon the pacemaker tissue of the heart.
4. In the heart-lung preparation of the dog there is a great variability of initial rate and of acceleration achieved by continuous infusion of epinephrine under standard conditions. Nevertheless, the percentage inhibition of acceleration caused by the antiaccelerator action of the secondary veratrum alkamines is relatively uniform.
Footnotes
- Received January 19, 1950.
- 1950 by The American Society for Pharmacology and Experimental Therapeutics
JPET articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|